Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells
- 1 May 2001
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 47 (3) , 194-204
- https://doi.org/10.1002/pros.1063
Abstract
BACKGROUND: Mxi1, an antagonist of c‐Myc, maps to human chromosome 10q24‐q25, a region altered in a substantial fraction of prostate tumors. Mice deficient for Mxi1 exhibit significant prostate hyperplasia. We studied the ability of Mxi1 to act as a growth suppressor in prostate tumor cells.METHODS: We infected DU145 prostate carcinoma cells with an Mxi1‐expressing adenovirus (AdMxi1) in vitro, and measured Mxi1 expression, cell proliferation, soft agar colony formation, and cell cycle distribution. To explore mechanisms of Mxi1‐induced growth arrest, we performed gene expression analysis.RESULTS: AdMxi1 infection resulted in reduced cell proliferation, reduced soft agar colony formation, and a higher proportion of cells in the G2/M phase of the cell cycle. This G2/M growth arrest was associated with elevated levels of cyclin B, and reduced levels of c‐MYC and MDM2.CONCLUSIONS: The ability of AdMxi1 to suppress prostate tumor cell proliferation supports a role for Mxi1 loss in the pathogenesis of a subset of human prostate cancers. Prostate 47:194–204, 2001.Keywords
This publication has 44 references indexed in Scilit:
- The molecular role of Myc in growth and transformation: recent discoveries lead to new insightsThe FASEB Journal, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Molecular advances in prostate cancerCurrent Opinion in Oncology, 1997
- Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell linesInternational Urology and Nephrology, 1995
- Oncogene overexpression and de novo drug-resistance in human prostate cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- p53 and c-myc Expression in Stage A1 Prostatic Adenocarcinoma: Useful Prognostic Determinants?Journal of Urology, 1993
- Transgenic models for the study of prostate cancerCancer, 1993
- Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen miboleroneBritish Journal of Cancer, 1992
- Amplification, rearrangement, and elevated expression of c‐myc in the human prostatic carcinoma cell line LNCaPThe Prostate, 1989
- Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancersThe Prostate, 1987